{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-102389","form_type":"8-K","ticker":"BEAM","cik":"0001745999","company_name":"Beam Therapeutics Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.860269+00:00","generated_at":"2026-05-17T20:51:47.339956+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Beam Q2 net loss $102.3M; cash $1.2B; BEAM-302 17 patients dosed; BEAM-101 enrollment complete","bullets":["Net loss of $102.3M ($1.00/share) vs $91.1M loss ($1.11/share) in Q2 2024; R&D expense rose to $101.8M.","Cash, cash equivalents and marketable securities $1.2B as of June 30, 2025; runway into 2028.","BEAM-302 Phase 1/2: 17 patients dosed; expanded dose exploration underway; Part B enrollment initiated; data expected early 2026.","BEAM-101 BEACON trial: 30 SCD patients dosed (adults + first adolescent); updated data expected by end of 2025.","FDA granted orphan drug designation for BEAM-101 and BEAM-302, and RMAT designation for BEAM-302."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-102389","json":"https://secwatch.observer/filing/0000950170-25-102389.json","markdown":"https://secwatch.observer/filing/0000950170-25-102389.md","text":"https://secwatch.observer/filing/0000950170-25-102389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025102389/0000950170-25-102389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025102389/beam-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:51:47.339956+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}